Surprisingly, the single tumor bearing NF1 A699Ifs*3 did not have a positive MPAS score, however, the allelic frequency of this variant was only 0.1, so loss of this TSG may have been insufficient to promote measurable MAP kinase pathway activation compared to oncogenic activators. The gene discussed is NF1; the disease is neoplasm.